Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Double-Blind, Placebo-Controlled Trial of Escitalopram as a Mood Stabilizer for Bipolar II Disorder

NCT00156325 is registered in ClinicalTrials.gov with The University of New South Wales as lead sponsor.

NCT NCT00156325
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00156325 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Double-Blind, Placebo-Controlled Trial of Escitalopram as a Mood Stabilizer for Bipolar II Disorder
Lead sponsor
The University of New South Wales
Phase
Phase 2
Overall status
Completed
Start date
February 29, 2004
Completion date
February 28, 2005
Enrollment
10
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bipolar disorders